✦ LIBER ✦

A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia

✍ Scribed by Naumann, M.; Yakovleff, A.; Durif, F.

Book ID: 113012311
Publisher: Springer
Year: 2002
Tongue: English
Weight: 309 KB
Volume: 249
Category: Article
ISSN: 0340-5354
DOI: 10.1007/pl00007848

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

0891 Comparison of the safety and effica

0891 Comparison of the safety and efficacy of botulinum toxin type-A and tizanidine in the treatment of cervical dystonia

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Long-term treatment of cervical dystonia

Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency

✍ Kirn R. Kessler; Michael Skutta; R. Benecke; for the German Dystonia Study Group 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 167 KB

Efficacy and safety of botulinum type A

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double-blind, placebo-controlled study

✍ Daniel Truong; Drake D. Duane; Joseph Jankovic; Carlos Singer; Lauren C. Seeberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia. This multicenter, double‐blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States. Ei

Efficacy of Dysport® (Botulinum toxin ty

Efficacy of Dysport® (Botulinum toxin type A) for the treatment of cervical dystonia: A multicenter, randomized, double-blind, placebo-controlled phase III study

✍ Truong Daniel; Lew Mark; Orlova Olga 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A multicenter, double-blind, randomized,

A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines

✍ J.Alastair Carruthers; Nicholas J. Lowe; M.Alan Menter; John Gibson; Marian Nord 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 812 KB

A four-month randomized, double-masked e

A four-month randomized, double-masked evaluation of the efficacy of botulinum toxin type a for the treatment of glabellar lines in women with skin types V and VI

✍ Pearl E. Grimes; Maria Meraz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB